Hypertriglyceridaemia-Associated Acute Pancreatitis: Pathophysiological Insights and Advances in Clinical Management

Area of Science:

• Metabolic disorders and gastroenterology
• Lipid metabolism and pancreatitis research
• Clinical review of hypertriglyceridaemia-induced acute pancreatitis

Background:

• Hypertriglyceridaemia (HTG) is a growing cause of acute pancreatitis (AP), linked to rising metabolic disorders.
• HTG-AP risk involves genetic factors and metabolic stressors, with higher risks of organ failure and recurrence.
• Current guidelines stress early risk stratification and supportive care, but HTG-specific treatments lack robust evidence.

Purpose of the Study:

• To synthesize current knowledge on the etiology, pathophysiology, and clinical features of HTG-AP.
• To review contemporary management strategies, including insulin therapy and lipid removal techniques.
• To highlight recent advancements, unresolved issues, and future directions in HTG-AP research.

Main Methods:

• Comprehensive literature review of HTG-AP.
• Synthesis of data on mechanisms, clinical presentation, and treatment outcomes.
• Analysis of current guidelines and emerging evidence.

Main Results:

• HTG-AP involves lipotoxic injury, microcirculatory dysfunction, and inflammation.
• Management strategies like insulin and plasmapheresis are common but lack strong supporting evidence.
• Long-term prevention requires aggressive lipid management and addressing metabolic risk factors.

Conclusions:

• HTG-AP is a significant clinical challenge requiring tailored management approaches.
• Further high-quality research is needed to optimize treatment strategies and improve patient outcomes.
• Precision medicine holds promise for future HTG-AP management.